Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-
Journal
ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411
Informations de publication
Date de publication:
14 Apr 2023
14 Apr 2023
Historique:
received:
14
11
2022
pmc-release:
10
03
2024
medline:
21
4
2023
pubmed:
21
4
2023
entrez:
21
04
2023
Statut:
epublish
Résumé
Analogues of 4-phosphoryloxy-
Identifiants
pubmed: 37082754
doi: 10.1021/acsptsci.2c00222
pmc: PMC10111620
doi:
Types de publication
Journal Article
Langues
eng
Pagination
567-577Informations de copyright
© 2023 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare the following competing financial interest(s): A.R.C. has an ownership stake in CaaMTech, Inc., owning patent applications concerning new tryptamine compounds, their compositions, formulations, method of use, and their syntheses. No other authors report any competing financial interests related to the data in this publication.
Références
Biochem Biophys Res Commun. 2022 Apr 2;598:20-25
pubmed: 35149433
J Antibiot (Tokyo). 2020 Oct;73(10):679-686
pubmed: 32398764
Neuron. 2007 Feb 1;53(3):439-52
pubmed: 17270739
Psychopharmacology (Berl). 1988;94(2):213-6
pubmed: 3127847
Neuropharmacology. 2018 Nov;142:240-250
pubmed: 29501528
Clin Pharmacol Ther. 2017 Feb;101(2):209-219
pubmed: 28019026
Pharmacol Biochem Behav. 2002 May;72(1-2):29-37
pubmed: 11900766
Eur J Pharmacol. 1990 Sep 4;186(1):115-8
pubmed: 2282932
ACS Chem Neurosci. 2018 Oct 17;9(10):2438-2447
pubmed: 29956917
J Psychopharmacol. 2016 Dec;30(12):1268-1278
pubmed: 27578767
J Psychopharmacol. 2008 Aug;22(6):603-20
pubmed: 18593734
Int J Neuropsychopharmacol. 2018 Oct 1;21(10):926-931
pubmed: 29850881
Neuropharmacology. 2022 Sep 1;215:109166
pubmed: 35718005
Life Sci. 1984 Dec 17;35(25):2505-11
pubmed: 6513725
ACS Chem Neurosci. 2015 Jul 15;6(7):1165-75
pubmed: 25547199
ACS Pharmacol Transl Sci. 2020 Dec 29;4(2):467-471
pubmed: 33860176
J Neurosci. 2010 Oct 6;30(40):13513-24
pubmed: 20926677
Pharmacol Rev. 2016 Apr;68(2):264-355
pubmed: 26841800
Neuropsychopharmacology. 2022 Mar;47(4):914-923
pubmed: 34750565
Curr Top Behav Neurosci. 2018;36:159-199
pubmed: 28224459
JAMA Psychiatry. 2021 Feb 1;78(2):121-122
pubmed: 32725172
Behav Brain Res. 2013 Nov 1;256:328-45
pubmed: 24004848
Hum Psychopharmacol. 2020 Jan;35(1):e2719
pubmed: 31909513
Neuropharmacology. 2011 Sep;61(3):364-81
pubmed: 21256140
J Neurosci. 2013 Jun 19;33(25):10544-51
pubmed: 23785166
Pharmacol Biochem Behav. 1990 Aug;36(4):901-6
pubmed: 2145593
Acta Crystallogr E Crystallogr Commun. 2021 Jan 08;77(Pt 2):101-106
pubmed: 33614134
ACS Pharmacol Transl Sci. 2022 Nov 02;5(11):1181-1196
pubmed: 36407948
Eur Neuropsychopharmacol. 2016 Apr;26(4):756-66
pubmed: 26875114
ACS Chem Neurosci. 2020 Dec 2;11(23):3979-3992
pubmed: 33164503
J Psychopharmacol. 2011 Nov;25(11):1548-61
pubmed: 21148021
J Pharmacol Exp Ther. 2023 Apr;385(1):62-75
pubmed: 36669875
J Pharmacol Exp Ther. 1997 Feb;280(2):576-83
pubmed: 9023266
Curr Top Behav Neurosci. 2022;56:213-227
pubmed: 35704271
Neuroreport. 1998 Dec 1;9(17):3897-902
pubmed: 9875725
J Nat Prod. 2020 Feb 28;83(2):461-467
pubmed: 32077284
Eur Neuropsychopharmacol. 2016 Aug;26(8):1327-37
pubmed: 27216487
Handb Exp Pharmacol. 2018;252:227-260
pubmed: 29532180
Synapse. 2000 Feb;35(2):144-50
pubmed: 10611640
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1079-84
pubmed: 18195357
Neuropharmacology. 2003 Jun;44(8):1047-53
pubmed: 12763098
Psychopharmacology (Berl). 2022 Jun;239(6):1783-1796
pubmed: 35487983
ACS Pharmacol Transl Sci. 2022 Apr 08;5(5):321-330
pubmed: 35592434
Drug Test Anal. 2012 Jul-Aug;4(7-8):556-76
pubmed: 22517680
Am J Addict. 2016 Aug;25(5):400-7
pubmed: 27419383
Sci Rep. 2021 Sep 3;11(1):17690
pubmed: 34480046
Psychopharmacol Bull. 1986;22(3):953-8
pubmed: 3025916
Pharmacol Biochem Behav. 2012 Jul;102(1):88-94
pubmed: 22487771
Behav Pharmacol. 2017 Aug;28(5):375-385
pubmed: 28537942
Curr Top Behav Neurosci. 2018;36:45-73
pubmed: 28677096
Psychopharmacology (Berl). 2014 Oct;231(21):4135-44
pubmed: 24800892
ACS Pharmacol Transl Sci. 2020 Dec 14;4(2):533-542
pubmed: 33860183
Neuropharmacology. 2018 Nov;142:231-239
pubmed: 29499272
Eur Neuropsychopharmacol. 2021 Aug;49:69-92
pubmed: 33857740
ACS Chem Neurosci. 2022 Aug 17;13(16):2436-2448
pubmed: 35900876
Neuropsychopharmacology. 2022 Mar;47(4):924-932
pubmed: 34802041
Arch Toxicol. 2020 Oct;94(10):3449-3460
pubmed: 32627074
Drug Test Anal. 2018 Feb;10(2):310-322
pubmed: 28585392
Neuropsychopharmacology. 2019 Jun;44(7):1328-1334
pubmed: 30685771
Psychopharmacology (Berl). 2006 Oct;188(2):244-51
pubmed: 16915381
Biomed Pharmacother. 2022 Oct;154:113612
pubmed: 36049313